...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells.
【24h】

Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells.

机译:Raxofelast(IRFI-016)在H2O2刺激的大鼠主动脉平滑肌细胞中的抗增殖机制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reactive oxygen species-mediated cellular injury is involved in the pathogenesis of many diseases, including those affecting the cardiovascular system, such as myocardial ischemia-reperfusion injury, inflammation, and atheroscleosis. Raxofelast (IRFI-016; (+/-)-5-acetoxy-2, 3-dihydro-4, 6, 7-trimethyl-2-benzofuran-acetic acid) was designed with the aim of maximizing the antioxidant potency of phenols chemically related to vitamin E. The antioxidant activity of raxofelast has been convincingly demonstrated in several in vitro studies and in various models of ischemia-reperfusion injury. In this study, the antiproliferative effects of raxofelast were investigated to determine whether transduction signals and protooncogenes are affected in H(2)O(2)-stimulated rat aortic smooth muscle cells. In a tetrazolium-based colorimetric assay, the proliferation of rat aortic smooth muscle cells was increased by 3-fold in 0.1% fetal bovine serum/Dulbecco's modified Eagle's medium (DMEM) containing 500 microM H(2)O(2), indicating that exogenous 500 microM H(2)O(2) was a growth stimulator of rat aortic smooth muscle cells. Exogenous H(2)O(2) significantly activated extracellular signal-regulated kinases (ERKs) activity within 30 min and raxofelast inhibited the ERKs activation dose dependently in 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells (IC(50): 200 microM). Raxofelast reduced the intracellular reactive oxygen species generated by exogenous H(2)O(2) in a dose-dependent manner. In 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells, raxofelast dramatically attenuated the activation of mitogen-activating protein kinase (MAPK)/ERK kinase 1, 2 (MEK1,2) and protein kinase C (PKC) without affecting Ras expression. Induction of c-myc mRNA was significantly reduced dose dependently up to 100 microM by raxofelast in concentrations. These data indicate that the antiproliferative effects of raxofelast in H(2)O(2)-stimulated rat aortic smooth muscle cells may involve the suppression of intracellular reactive oxygen species formation and the inhibition of ERKs by inactivation through PKC and MEK1,2 and down-regulation of c-myc expression, regardless of Ras activation.
机译:活性氧介导的细胞损伤与许多疾病的发病机理有关,包括影响心血管系统的疾病,例如心肌缺血-再灌注损伤,炎症和动脉粥样硬化。 Raxofelast(IRFI-016;(+/-)-5-乙酰氧基-2,3-dihydro-4,6,7-三甲基-2-苯并呋喃-乙酸)的设计旨在最大程度地化学提高酚的抗氧化能力Raxofelast的抗氧化活性已在多项体外研究和各种缺血再灌注损伤模型中令人信服地证明。在这项研究中,研究了raxofelast的抗增殖作用,以确定在H(2)O(2)刺激的大鼠主动脉平滑肌细胞中是否存在转导信号和原癌基因。在基于四氮唑的比色测定中,大鼠主动脉平滑肌细胞的增殖在0.1%胎牛血清/ Dulbecco改良的Eagle培养基(DMEM)中包含500 microM H(2)O(2)的3倍增加。外源性500 microM H(2)O(2)是大鼠主动脉平滑肌细胞的生长刺激物。外源性H(2)O(2)在30分钟内显着激活了细胞外信号调节激酶(ERKs)的活性,而axofelast抑制了ERKs的激活剂量,依赖于500 microM H(2)O(2)刺激的大鼠主动脉平滑肌细胞( IC(50):200 microM)。 Raxofelast以剂量依赖性方式减少了外源性H(2)O(2)生成的细胞内活性氧种类。在500 microM H(2)O(2)刺激的大鼠主动脉平滑肌细胞中,raxofelast显着减弱了促分裂原活化蛋白激酶(MAPK)/ ERK激酶1、2(MEK1,2)和蛋白激酶C(PKC ),而不会影响Ras表达。浓度为raxofelast时,剂量依赖性地将c-myc mRNA的诱导显着降低至100 microM。这些数据表明raxofelast在H(2)O(2)刺激的大鼠主动脉平滑肌细胞中的抗增殖作用可能涉及抑制细胞内活性氧的形成,并通过PKC和MEK1,2失活而抑制ERKs,并降低-c-myc表达的调节,与Ras激活无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号